Literature DB >> 2862287

Antiarrhythmic and electrophysiological effects of alpha adrenoceptor blockade during myocardial ischaemia and reperfusion in isolated guinea-pig heart.

W J Penny, W Culling, M J Lewis, D J Sheridan.   

Abstract

An isolated buffer perfused guinea-pig heart preparation has been used to study the antiarrhythmic and cellular electrophysiological effects of alpha adrenoceptor blockade during myocardial ischaemia and reperfusion. Phentolamine 5 X 10(-6) M and indoramin 2 X 10(-6) M significantly reduced the incidence of ventricular tachycardia (VT) and ventricular fibrillation (VF) during ischaemia and reperfusion. Both drugs prolonged action potential duration (APD) and refractory period and reduced Vmax during normal perfusion and these effects were maintained during ischaemia. Reperfusion led to prompt recovery in all hearts but with initial transient shortening of APD. Phentolamine and indoramin abolished shortening of the APD whether added prior to ischaemia or immediately prior to reperfusion, and attenuated the reduction in refractory period, due to higher values at the end of ischaemia. Myocardial catecholamine depletion also significantly reduced ventricular tachycardia and ventricular fibrillation during ischaemia and reperfusion. Catecholamine depletion had similar effects on APD, refractory period and conduction, but phentolamine produced no additional effects when added to catecholamine depleted hearts suggesting that the effects observed here are mediated via adrenergic rather than direct myocardial effects.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2862287     DOI: 10.1016/s0022-2828(85)80139-5

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  10 in total

Review 1.  Role of calcium ions in reperfusion arrhythmias: relevance to pharmacologic intervention.

Authors:  L H Opie; W A Coetzee
Journal:  Cardiovasc Drugs Ther       Date:  1988-12       Impact factor: 3.727

2.  Anti-arrhythmic properties of the alpha-adrenoceptor blocking drug indoramin.

Authors:  M A James; J V Jones
Journal:  Br J Clin Pharmacol       Date:  1991-09       Impact factor: 4.335

3.  Effects of alpha adrenergic blockade during stellate ganglion stimulation on arrhythmias induced by acute myocardial ischemia in pigs.

Authors:  A R Zou; S R Li; Y Zhang; H Pei
Journal:  J Tongji Med Univ       Date:  1991

4.  beta 2-Adrenergic stimulation is involved in the contractile dysfunction of the stunned heart.

Authors:  Leticia Vittone; Matilde Said; Alicia Mattiazzi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-03-31       Impact factor: 3.000

5.  Phentolamine and hypoxia: modulation of contractility and alpha 1-adrenoceptors in isolated rat atria.

Authors:  G Froldi; L Guerra; L Pandolfo; A Chinellato; E Ragazzi; L Caparrotta; P A Borea; G Fassina
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-11       Impact factor: 3.000

6.  Positive inotropic action of angiotensin II in the pithed rat.

Authors:  J Zhang; M Pfaffendorf; P A van Zwieten
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-06       Impact factor: 3.000

7.  Electrophysiological and antiarrhythmic effects of UK 52,046-27 during ischaemia and reperfusion in the guinea-pig heart.

Authors:  N A Flores; D J Sheridan
Journal:  Br J Pharmacol       Date:  1989-03       Impact factor: 8.739

8.  Cardiac alpha 1-adrenoceptor densities in different mammalian species.

Authors:  M Steinfath; Y Y Chen; J Lavický; O Magnussen; M Nose; S Rosswag; W Schmitz; H Scholz
Journal:  Br J Pharmacol       Date:  1992-09       Impact factor: 8.739

Review 9.  Role of calcium and other ions in reperfusion injury.

Authors:  L H Opie
Journal:  Cardiovasc Drugs Ther       Date:  1991-03       Impact factor: 3.727

10.  Comparative antiarrhythmic and electrophysiological effects of drugs known to inhibit calmodulin (TFP, W7 and bepridil).

Authors:  E Barron; R J Marshall; M Martorana; E Winslow
Journal:  Br J Pharmacol       Date:  1986-11       Impact factor: 8.739

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.